The Manila Times

Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide

Arch Biopartners Inc. ('Arch” or the 'Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the University ...